Bayer diabetes business sale not imminent: sources

FRANKFURT (Reuters) - German drugmaker Bayer is in talks to sell its diabetes devices division but a sale is not imminent, two sources with knowledge of the matter told Reuters.

via Reuters: Health News Read More Here..